SUB1 and prostate carcinoma: Furthermore, SUB1 overexpression elevated PLK1 and C-MYC expression, and reduced CDKN1B expression (Figure 4c and Supplementary Figure S6c), showing SUB1 dysregulation triggers alterations in critical oncogenes and tumor suppressors in prostate cancer.